Viewing Study NCT00128856


Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2026-04-04 @ 7:45 AM
Study NCT ID: NCT00128856
Status: COMPLETED
Last Update Posted: 2023-03-06
First Post: 2005-08-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer Patients
Sponsor: Spanish Breast Cancer Research Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neoadjuvant chemotherapy. View
None Stage III disease. View